Literature DB >> 1151160

The influence of serum calcium and parathyroid hormone upon glucose metabolism in uremia.

W J Amend, S M Steinberg, E G Lowrie, J M Lazarus, J S Soeldner, C L Hampers, J P Merrill.   

Abstract

The alterations in carbohydrate metabolism which attend the uremic syndrome have been recognized for some time. Recently, an interaction between hyperparathyroidism and these alterations in intermediary metabolism has been postulated. To further define any such interaction, 6 stable dialysis patients with significant secondary hyperparathyroidism were studied prior to and after subtotal parathyroidectomy. Glucose utilization and insulin secretion were estimated by use of a standard intravenous glucose tolerance test and the resistance of peripheral tissues to exogenous insulin was evaluated by insulin tolerance testing. All of peripheral tissues to exogenous insulin was evaluated by insulin tolerance testing. All patients were studied under baseline conditions, as well as induced hyper- and hypocalcemia, prior to and at least 2 months after surgery. Parathyroidectomy, per se, had no significant effect upon glucose utilization, insulin secretion, or the resistance of peripheral tissues to the action of exogenous insulin. Both induced hyper- and hypocalcemia, on the other hand, significantly diminished glucose utilization as judged by a reduced glucose disappearance rate during intravenous glucose tolerance testing. Hypocalcemia was associated with a markedly reduced insulin secretory response and normal tissue insulin sensitivity, while hypercalcemia was associated with a normal insulin response but reduced tissue sensitivity. The data suggest that calcium ion concentration may affect both glucose utilization and insulin secretion. As such, it must be adequately controlled in furture metabolic studies.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1151160

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  6 in total

1.  The relative roles of calcium, phosphorus, and parathyroid hormone in glucose- and tolbutamide-mediated insulin release.

Authors:  H R Harter; J V Santiago; W E Rutherford; E Slatopolsky; S Klahr
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

2.  Carbohydrate metabolism and uraemia-mechanisms for glycogenolysis and gluconeogenesis.

Authors:  W H Hörl; J Stepinski; A Heidland
Journal:  Klin Wochenschr       Date:  1980-10-01

3.  Abnormal carbohydrate metabolism in chronic renal failure. The potential role of accelerated glucose production, increased gluconeogenesis, and impaired glucose disposal.

Authors:  S Rubenfeld; A J Garber
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

4.  Role of parathyroid hormone in the glucose intolerance of chronic renal failure.

Authors:  M Akmal; S G Massry; D A Goldstein; P Fanti; A Weisz; R A DeFronzo
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

5.  A pilot study of active vitamin D administration and insulin resistance in African American patients undergoing chronic hemodialysis.

Authors:  Adriana M Hung; Mary B Sundell; Natalia E Plotnikova; Aihua Bian; Ayumi Shintani; Charles D Ellis; Edward D Siew; T Alp Ikizler
Journal:  J Ren Nutr       Date:  2012-09-07       Impact factor: 3.655

Review 6.  Parathyroid Hormone: A Uremic Toxin.

Authors:  Eduardo J Duque; Rosilene M Elias; Rosa M A Moysés
Journal:  Toxins (Basel)       Date:  2020-03-17       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.